P3 Health Partners Inc. Class A PIII 深 沪
等待开盘 07-25 09:30:00 美东时间
9.47
+0.160
+1.72%
华盛通- 最 高9.47
- 今 开9.12
- 成交量 7184股
- 最 低 9.12
- 昨 收 9.31
- 总市值 6861.00万
- 52周最高 16.89
- 市盈率 静 --
- 换手率 0.10%
- 52周最低 1.52
- 委 比 2.44%
- 总股本 724.50万
- 历史最高 836.50
- 量 比 0.72
- 振 幅 3.76%
- 历史最低 1.52
- 每 手 1
- 风险率 3.44%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Friday's After-Market Session
Gainers INVO Fertility (NASDAQ:IVF) shares increased by 33.0% to $2.5 during F...
05-30 05:05
TD Cowen Maintains Hold on P3 Health Partners, Raises Price Target to $14
TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and raises the price target from $3 to $14.
05-22 22:38
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 635.6% to $2.0...
05-18 20:05
美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
美股夜盘 | P3 Health Partners Inc. Class A跌20.73%，最新股价8.95美元
P3 Health Partners Inc. Class A跌20.73%，报8.95美元
05-18 08:41
美股夜盘 | DirectBooking Technology Co., Ltd. Class A涨38.62%，WEX Inc.涨19.54%
P3 Health Partners Inc. Class A涨-17.63%；Artelo Biosciences Inc涨-14.67%；Lantern Pharma, Inc.涨-12.42%
05-18 08:05
Why Figma Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Figma Inc (NYSE: FIG) shares rose 10.6% in pre-market trading after beating Q1 revenue and earnings estimates and raising FY26 sales guidance.
05-15 17:38
美股夜盘 | Dreamland Limited Class A涨103.75%，柏雅国际涨52.71%
Vuzix Corporation涨-14.94%；Concorde International Group Ltd. Class A涨-13.11%；Mobix Labs, Inc.涨-11.90%
05-15 08:05
P3 Health Partners shares are trading higher after the company reported better-than-expected Q1 EPS results.
P3 Health Partners shares are trading higher after the company reported better-...
05-15 04:32
P3 Health Partners Narrows FY2026 Sales Guidance from $1.500B-$1.700B to $1.500B-$1.650B vs $1.539B Est
P3 Health Partners (NASDAQ:PIII) narrows FY2026 sales outlook from $1.500 billion-$1.700 billion to $1.500 billion-$1.650 billion vs $1.539 billion estimate.
05-15 04:26
